Linkedin Share
Politics

FDA Pushes Through Emergency Authorization For Hydroxychloroquine As Coronavirus Treatment

Linkedin Share

It finally looks like there is a ray of hope in the fight against the coronavirus as the Food and Drug Administration has issued an emergency authorization this past weekend for the use of hydroxychloroquine as a treatment for the illness that is leaving a swath of devastation wherever it roams.

This particular kind of medication is typically used in the treatment of malaria, but when it is paired with azithromycin, has not yet been proven to be effective against the illness in clinical trials, however, there are growing numbers of reports and small studies that indicate it is having a positive impact on those with severe cases.

Check out more details from Breitbart:

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trending:
Massive Migrant Caravan Marches Toward US with LGBT Flags Flying as Mexican President Snubs Biden at Summit

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

One of the biggest concerns about using this medication to treat this illness with hydroxychloroquine is that there may now be a massive increase in demand for the drug which could lead to a shortage in the supply.

In order to curtail that problem, the HHS said, “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”

President Trump has taken an interest in how the drug could possibly be effective in helping to treat the coronavirus prompting him to encourage further studies be conducted on its efficacy, something that got him significant pushback from liberal media outlets.

The bottom line is, if those who are severely ill with coronavirus are at high risk of suffering severe complications that could lead to death, there’s no reason not to provide them with a medication that could potentially save their lives and reduce their suffering.

Submit a Correction →



Tags:
, , , , ,
Linkedin Share

Conversation